Zimmer Biomet Holdings, Inc.
ZBHStock
$93.75−4.14%52W
Market Cap$17.97B
P/E25.48x
Div yield1.04%
Beta0.48
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-12.19%
Price vs S&P 500 (4W)0.31%
VGM Score58.16
Market Capitalization$17.97B
P/E Ratio (Annual)25.48x
Indicated Dividend Yield (Annual)1.04%
Earnings Surprise History
Q1 262.09est. 1.88
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.32
3.31
3.41
3.41
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ZBHZimmer Biomet Holdings, Inc. | B | C | C | $93.75 |
| ISRGIntuitive Surgical Inc. | D | B | D | $402.33 |
| EWEdwards Lifesciences Corp | D | C | B | $87.84 |
| STESTERIS plc | B | B | C | $221.13 |
| ALGNAlign Technology Inc | C | C | C | $178.41 |
| SNNSmith & Nephew plc | B | C | C | $31.41 |
| MSAMine Safety Incorporated | C | C | C | $173.39 |
| ESTAEstablishment Labs Holdings Inc. | F | A | A | $92.30 |
| ENOVEnovis Corporation | B | D | C | $28.07 |
| CDRECadre Holdings, Inc. | B | C | D | $30.18 |
| AVNSAvanos Medical, Inc. | B | D | A | $24.96 |
About
Zimmer Biomet is a leading designer and manufacturer of orthopedic reconstructive implants and surgical equipment, with dominant market positions in the United States, Europe, and Japan. The company derives approximately two-thirds of revenue from large joint reconstructions, with the remainder from trauma, sports medicine, and extremities products. In 2022, Zimmer spun out its dental and spine businesses to focus on orthopedic reconstruction.